Skip to content

*Dutch Marines study on Rabies antibody response after Boostering an intradermal pre-exposure scheme (MaRaBoo study)*

*Dutch Marines study on Rabies antibody response after Boostering an intradermal pre-exposure scheme (MaRaBoo study)* - MaRaBoo study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON45312
Enrollment
150
Registered
2016-11-11
Start date
2016-11-22
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rabies

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Healthy military volunteers that received a completed intradermal immunization last year or 2 years ago.

Exclusion criteria

Exclusion criteria: - Age

Design outcomes

Primary

MeasureTime frame
The percentage of participants with a titer of * 0.5 IU/ml at day 7 The percentage of participants with a titer of * 0.5 IU/ml at day 14

Secondary

MeasureTime frame
The percentage of participants with a titer of * 0.5 IU/ml at day 0 The percentage of participants with a titer of * 3.0 IU/ml at day 7 The percentage of participants with a titer of * 3.0 IU/ml at day 14

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)